Norman D. Schwartz - 08 Mar 2024 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Chairman, President, and CEO, Director, 10%+ Owner
Signature
/s/ Norman Schwartz
Issuer symbol
BIO
Transactions as of
08 Mar 2024
Net transactions value
$0
Form type
4
Filing time
12 Mar 2024, 12:23:18 UTC
Previous filing
07 Dec 2023
Next filing
28 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIO BIOB Bio-Rad A Common Stock 432,920 08 Mar 2024 Direct
holding BIO BIOB Bio-Rad B Common Stock 361,409 08 Mar 2024 Direct
holding BIO BIOB Bio-Rad B Common Stock 12,949 08 Mar 2024 By Spouse F1
holding BIO BIOB Bio-Rad B Common Stock 4,060,054 08 Mar 2024 By Blue Raven Partners, L.P. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIOB Non-Qualified Stock Option (right to buy) Award $0 +14,137 $0.000000 14,137 08 Mar 2024 Bio-Rad A Common Stock 14,137 $343.76 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these shares.
F2 The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3 The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.